| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |